Phase 1 Results for ALLO-501 in Non-Hodgkin Lymphoma to be Presented at ASCO
All the news from Servier Group
Covid-19: Mécénat Servier sets up remote skills-based sponsorship missions
Golden Ticket 2020 awarded to Rgenta Therapeutics, a biotech specializing in diseases considered incurable
COVID-19: The “Health Innovation Coalition – Health Crisis” selects a new projects and the lengthens its call for projects until May 7th.
Final closing of the Kurma Biofund III fund
Mécénat Servier is mobilizing against school disengagement
Covid-19: The Health Innovation Coalition selects its first digital projects!
Servier, committed to helping those who fight against the Covid-19
COVID-19: Servier China on the digital innovation front